Physical Activity Level in Patients with Chronic Kidney Disease During COVID-19 Pandemic

NCT04745923 | Completed

• 1 other identifier: GO 21/127
• Study Type: observational
• Target: 190
• Locations: 1 country
• Sites: 1

Brief Summary

In the literature, there are no studies evaluating fear of COVID-19, anxiety, depression, physical activity, fear of movement and quality of life in patients with chronic kidney disease during COVID-19 pandemic. The investigators will evaluate these parameters in patients with chronic kidney disease and compare the findings of healthy individuals during COVID-19 pandemic

Conditions

Covid19; Chronic Kidney Diseases

Keywords

Fear; Quality of life; Anxiety; Depression

Outcome Measures

Primary Outcomes (2)

• Fear of COVID-19

  COVID-19 phobia will be evaluated using Fear of COVID-19 Scale.

  5 minutes

• Physical activity

  Physical activity level will be evaluated using International Physical Activity Questionnaire - Short Form (IPAQ-SF).

  5 minutes

Secondary Outcomes (3)

• Qol

  10 minutes

• Anxiety and depression

  5 minutes

• Fear of movement

  10 minutes

Study Arms (2)

Patients with chronic kidney disease

Having been diagnosed with chronic kidney disease

Healthy individuals

Healthy individuals without chronic disease

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients and healthy individuals between 18-65 years old, who are diagnosed with chronic kidney disease, and whose local language is Turkish will be included in the study.

You may qualify if:

• Having been diagnosed with chronic kidney disease
• Being clinically stable
• Volunteering to participate in the research

You may not qualify if:

• Having a cognitive problem
• Not being literate

Sponsors & Collaborators

• Hacettepe University: lead

Study Sites (1)

Hacettepe University, Faculty of Physical Therapy and Rehabilitation

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19; Renal Insufficiency, Chronic; Anxiety Disorders; Depression

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Mental Disorders; Behavioral Symptoms; Behavior

Study Officials

• Merve Firat, MSc

  Hacettepe University

  PRINCIPAL INVESTIGATOR

• Naciye Vardar-Yagli, PhD

  Hacettepe University

  STUDY DIRECTOR

• Tolga Yildirim, MD

  Hacettepe University

  STUDY CHAIR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research assistant

Study Record Dates

• First Submitted: February 6, 2021
• First Posted: February 9, 2021
• Study Start: January 20, 2021
• Primary Completion: February 28, 2021
• Study Completion: September 30, 2022
• Last Updated: November 7, 2024

Record last verified: 2021-01

Locations

TU (1)